WID
LIVE

Serial Number

97150184

Owner

Sola Diagnostics GmbH

Attorney

John Mueller

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

WID Trademark

Serial Number: 97150184 • Registration: 7307764

WID is a trademark filed by Sola Diagnostics GmbH on December 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Sola Diagnostics GmbH (2 trademarks)

Hauptplatz 4
Zams 6511 , AT

Entity Type: 99

Trademark Details

Filing Date

December 1, 2021

Registration Date

February 20, 2024

Published for Opposition

December 5, 2023

Goods & Services

Diagnostic biomarker reagents for medical purposes used in connection with a cervical swab to identify gynaecologic cancers of the cervix, uterine body, ovary and breast; diagnostic kits comprised of medical assays for testing bodily fluids, bodily tissue and blood for use in disease detection, namely, gynecological cancer and, in particular, cervical, uterine, ovarian and breast cancers; diagnostic reagents in kit form consisting of kits comprised primarily of diagnostic reagents for conducting assays for medical purposes; medical in vitro diagnostic reagents for polymerase chain reaction (pcr) technologies; medical diagnostic reagents; epigenetic test kits comprising reagents for testing and analysing bodily fluids, bodily tissue and blood for the diagnosis and detection of cancer; diagnostic reagents and kits of comprised primarily of diagnostic reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic use

Medical diagnostic services; medical testing services relating to the diagnosis and treatment of diseases; medical diagnostic testing relating to the human body; blood testing services; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular testing and analysis services and DNA/RNA sequencing services for medical purposes; consultancy, advisory and information services relating to medical research and development in the field of cancer diagnosis and detection

Medical apparatus for diagnostic testing of biological samples, namely, bodily fluids, body tissues and blood for the detection of cancer and disease; medical diagnostic apparatus for use in analytical tests for detecting cancer and disease from sample bodily fluids, bodily tissue and blood; instruments for making cervical smears; DNA and epigenetics testing apparatus for medical use; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations in relation to gynecological cancers of the cervix, uterine body, ovary and breast

Scientific research for chemical, biochemical, biological or bacteriological purposes; scientific research for medical purposes; scientific and medical research services; electronic data storage services; scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of acquired or inherited genetic mutations, and for detection and analysis of epigenetic alterations; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 5, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 5, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 5, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 20, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 20, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 5, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 19, 2023 ERFR
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Oct 18, 2023 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Oct 18, 2023 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Oct 18, 2023 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 17, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 19, 2023 GNFN
FINAL REFUSAL E-MAILED
Jul 19, 2023 GNFR
FINAL REFUSAL WRITTEN
Jul 19, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2023 CRFA
ASSIGNED TO LIE
Jul 17, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP